Imidazoquinoline Derivatives as Potential Inhibitors of InhA Enzyme and Mycobacterium tuberculosis
Molecules · 2024
DOI: 10.3390/molecules29133076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Pascal Hoffmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique (SPCMIB), UMR5068, CNRS, Université Paul Sabatier Toulouse III, 31062 Tou…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Bacterial Proteins, Oxidoreductases, Antitubercular Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre National de la Recherche Scientifique (CNRS, France), Université Paul Sabatier Toulouse III (France).
Abstract (Originalsprache)
Tuberculosis is a serious public health problem worldwide. The search for new antibiotics has become a priority, especially with the emergence of resistant strains. A new family of imidazoquinoline derivatives, structurally analogous to triazolophthalazines, which had previously shown good antituberculosis activity, were designed to inhibit InhA, an essential enzyme for Mycobacterium tuberculosis survival. Over twenty molecules were synthesized and the results showed modest inhibitory efficacy against the protein. Docking experiments were carried out to show how these molecules could interact with the protein’s substrate binding site. Disappointingly, unlike triazolophthlazines, these imidazoquinoline derivatives showed an absence of inhibition on mycobacterial growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire de Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique (SPCMIB), UMR5068, CNRS, Université Paul Sabatier Toulouse III, 31062 Toulouse, France.
- Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, 27100 Pavia, Italy.
- Institut de Chimie de Toulouse, ICT-UAR2599, Université Paul Sabatier Toulouse III, 31062 Toulouse, France.
ORCID-Profile: Pascal Hoffmann, Fernanda Goncalves, Alessandro Stamilla, Frédéric Rodriguez, Giulia Degiacomi, Maria Rosalia Pasca, Christian Lherbet
Förderung
- Centre National de la Recherche Scientifique (CNRS, France)
- Université Paul Sabatier Toulouse III (France)
Zitieren
APA
Hoffmann, P., Azéma-Despeyroux, J., Goncalves, F., Stamilla, A., Saffon-Merceron, N., Rodriguez, F., Degiacomi, G., Pasca, M. R., & Lherbet, C. (2024). Imidazoquinoline Derivatives as Potential Inhibitors of InhA Enzyme and Mycobacterium tuberculosis. Molecules. https://doi.org/10.3390/molecules29133076
Vancouver
Hoffmann P, Azéma-Despeyroux J, Goncalves F, Stamilla A, Saffon-Merceron N, Rodriguez F, et al. Imidazoquinoline Derivatives as Potential Inhibitors of InhA Enzyme and Mycobacterium tuberculosis. Molecules. 2024. doi:10.3390/molecules29133076
BibTeX
@article{Hoffmann2024,
author = {Hoffmann, Pascal and Azéma-Despeyroux, Joëlle and Goncalves, Fernanda and Stamilla, Alessandro and Saffon-Merceron, Nathalie and Rodriguez, Frédéric and Degiacomi, Giulia and Pasca, Maria Rosalia and Lherbet, Christian},
title = {Imidazoquinoline Derivatives as Potential Inhibitors of InhA Enzyme and Mycobacterium tuberculosis},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29133076}
}
EUVIMED